Literature DB >> 24948815

Gene-environment interactions: lifetime cognitive activity, APOE genotype, and β-amyloid burden.

Miranka Wirth1, Sylvia Villeneuve2, Renaud La Joie2, Shawn M Marks2, William J Jagust3.   

Abstract

Carriers of the apolipoprotein E (APOE) ε4 allele, the major genetic risk for Alzheimer's disease (AD), harbor an increased load of β-amyloid (Aβ) plaque burden that is felt to be a major instigator of AD development. Data has suggested that lifestyle factors may reduce AD risk by directly mitigating Aβ pathology, which could be particularly beneficial in APOE ε4 carriers. We therefore examined the interaction between lifetime cognitive activity and the APOE ε4 allele in relation to brain Aβ burden. We obtained measures of lifetime cognitive activity in 118 cognitively normal human individuals (mean age: 76.13 ± 5.56 years, 70 women) using a validated questionnaire that included measures over early, middle, and current age epochs. Hierarchical regression models (adjusted for age, gender, and years of education) were conducted to examine effects of APOE ε4 carrier status, lifetime cognitive activity, and the interaction of the two factors with cortical Aβ deposition, quantified using [11C] Pittsburgh-compound-B (PIB)-PET. As expected, the ε4 carriers exhibited higher PIB retention compared with noncarriers. Lifetime cognitive activity moderated the APOE genotype effect such that cortical PIB retention was diminished in ε4 carriers that reported higher cognitive activity over the life course. The findings suggest that greater lifetime cognitive activity may forestall AD pathology, specifically in genetically susceptible individuals. The effect could imply that cognitive training promotes increased neural efficiency that might retard the lifelong neurally mediated deposition of Aβ.
Copyright © 2014 the authors 0270-6474/14/348612-06$15.00/0.

Entities:  

Keywords:  APOE; Alzheimer's disease; PIB-PET; aging; lifestyle activity; β-amyloid

Mesh:

Substances:

Year:  2014        PMID: 24948815      PMCID: PMC4061397          DOI: 10.1523/JNEUROSCI.4612-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  41 in total

1.  Assessment of lifetime participation in cognitively stimulating activities.

Authors:  Robert Wilson; Lisa Barnes; David Bennett
Journal:  J Clin Exp Neuropsychol       Date:  2003-08       Impact factor: 2.475

2.  Cognitive activity and incident AD in a population-based sample of older persons.

Authors:  R S Wilson; D A Bennett; J L Bienias; N T Aggarwal; C F Mendes De Leon; M C Morris; J A Schneider; D A Evans
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

3.  Association between physical activity and markers of inflammation in a healthy elderly population.

Authors:  D F Geffken; M Cushman; G L Burke; J F Polak; P A Sakkinen; R P Tracy
Journal:  Am J Epidemiol       Date:  2001-02-01       Impact factor: 4.897

4.  A questionnaire for the assessment of leisure time physical activities.

Authors:  H L Taylor; D R Jacobs; B Schucker; J Knudsen; A S Leon; G Debacker
Journal:  J Chronic Dis       Date:  1978

5.  Participation in cognitively stimulating activities and risk of incident Alzheimer disease.

Authors:  Robert S Wilson; Carlos F Mendes De Leon; Lisa L Barnes; Julie A Schneider; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  JAMA       Date:  2002-02-13       Impact factor: 56.272

6.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.

Authors:  Eric M Reiman; Kewei Chen; Gene E Alexander; Richard J Caselli; Daniel Bandy; David Osborne; Ann M Saunders; John Hardy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

7.  Distribution volume ratios without blood sampling from graphical analysis of PET data.

Authors:  J Logan; J S Fowler; N D Volkow; G J Wang; Y S Ding; D L Alexoff
Journal:  J Cereb Blood Flow Metab       Date:  1996-09       Impact factor: 6.200

8.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

9.  Video game training enhances cognitive control in older adults.

Authors:  J A Anguera; J Boccanfuso; J L Rintoul; O Al-Hashimi; F Faraji; J Janowich; E Kong; Y Larraburo; C Rolle; E Johnston; A Gazzaley
Journal:  Nature       Date:  2013-09-05       Impact factor: 49.962

View more
  53 in total

Review 1.  Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress.

Authors:  Mohammed Akbar; Musthafa Mohamed Essa; Ghazi Daradkeh; Mohamed A Abdelmegeed; Youngshim Choi; Lubna Mahmood; Byoung-Joon Song
Journal:  Brain Res       Date:  2016-02-13       Impact factor: 3.252

2.  Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.

Authors:  Anja Soldan; Corinne Pettigrew; Yi Lu; Mei-Cheng Wang; Ola Selnes; Marilyn Albert; Timothy Brown; J Tilak Ratnanather; Laurent Younes; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2015-04-16       Impact factor: 5.038

Review 3.  Defining Cognitive Reserve and Implications for Cognitive Aging.

Authors:  Corinne Pettigrew; Anja Soldan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-01-09       Impact factor: 5.081

4.  Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories.

Authors:  Brian J Lopresti; Elizabeth M Campbell; Zheming Yu; Stewart J Anderson; Ann D Cohen; Davneet S Minhas; Beth E Snitz; Sarah K Royse; Carl R Becker; Howard J Aizenstein; Chester A Mathis; Oscar L Lopez; William E Klunk; Dana L Tudorascu
Journal:  Neurobiol Aging       Date:  2020-05-31       Impact factor: 4.673

5.  Clustering-initiated factor analysis application for tissue classification in dynamic brain positron emission tomography.

Authors:  Rostyslav Boutchko; Debasis Mitra; Suzanne L Baker; William J Jagust; Grant T Gullberg
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-22       Impact factor: 6.200

6.  Cognitive activity relates to cognitive performance but not to Alzheimer disease biomarkers.

Authors:  Christopher M Gidicsin; Jacqueline E Maye; Joseph J Locascio; Lesley C Pepin; Marlie Philiossaint; J Alex Becker; Alayna P Younger; Maria Dekhtyar; Aaron P Schultz; Rebecca E Amariglio; Gad A Marshall; Dorene M Rentz; Trey Hedden; Reisa A Sperling; Keith A Johnson
Journal:  Neurology       Date:  2015-06-10       Impact factor: 9.910

7.  Beta-amyloid deposition in chronic traumatic encephalopathy.

Authors:  Thor D Stein; Philip H Montenigro; Victor E Alvarez; Weiming Xia; John F Crary; Yorghos Tripodis; Daniel H Daneshvar; Jesse Mez; Todd Solomon; Gaoyuan Meng; Caroline A Kubilus; Kerry A Cormier; Steven Meng; Katharine Babcock; Patrick Kiernan; Lauren Murphy; Christopher J Nowinski; Brett Martin; Diane Dixon; Robert A Stern; Robert C Cantu; Neil W Kowall; Ann C McKee
Journal:  Acta Neuropathol       Date:  2015-05-06       Impact factor: 17.088

8.  Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment.

Authors:  Sylvia Villeneuve; William J Jagust
Journal:  J Prev Alzheimers Dis       Date:  2015-03

9.  Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders.

Authors:  Timothy C Durazzo; Niklas Mattsson; Michael W Weiner
Journal:  Nicotine Tob Res       Date:  2015-04-06       Impact factor: 4.244

10.  Characterizing the Molecular Architecture of Cortical Regions Associated with High Educational Attainment in Older Individuals.

Authors:  David Bartrés-Faz; Gabriel González-Escamilla; Lídia Vaqué-Alcázar; Kilian Abellaneda-Pérez; Cinta Valls-Pedret; Emilio Ros; Michel J Grothe
Journal:  J Neurosci       Date:  2019-04-08       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.